XBI $128 +2%
Covid Updates
BNTX +9% & PFE +1% Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of their COVID-19 Vaccine.
VIR +3% & GSK +1% Announce the Start of the EMA Rolling Review of VIR-7831 (sotrovimab) for the Early Treatment of COVID-19.
Pipeline Updates
VXRT +4% Vaxart Announces First Subject Enrolled in Phase 1b Norovirus Dose-Ranging Trial in Elderly Adults.
KMPH +7% Serdexmethylphenidate (SDX) Has Been Classified as a Schedule IV Controlled Substance by the DEA.
CCXI -62% Announces Results of FDA Advisory Committee Meeting on Avacopan in ANCA-Associated Vasculitis.